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Abstract: Viral agents of human gastroenteritis affect people of all ages across the globe. As a mainly
self-limiting disease, it is difficult to evaluate the real prevalence of etiological agents circulating
in each region. Many of the analyzed outbreaks are caused by viruses of the family Caliciviridae,
especially the genus Norovirus (NoV). Most studies have focused on other enteric viruses, leaving
sapovirus (SaV) underestimated as an important emerging human threat. This one-year study
analyzed clinical samples from hospital outpatients with acute gastroenteritis in Spain, with the
aim of revealing the importance of human SaV as an emerging viral pathogen. A total of 2667
stools were tested using reverse transcription (RT)-qPCR to detect and quantify SaV. Sapovirus was
detected in all age groups, especially in infants, children, and the elderly. The prevalence was 15.64%
(417/2667), and was slightly higher in 0–2- and 3–5-year-olds (19.53% and 17.95%, respectively)
and much lower in 13–18-year-olds (9.86%). Positive samples were detected throughout the year,
with peaks of detection during autumn and the late winter to early spring months. The mean value
for the quantified samples was 6.5 × 105 genome copies per gram of stool (GC/g) (range 2.4 ×
103–6.6 × 1011 GC/g). RT-nested PCR and sequencing were used for further genotyping. Genetic
characterization showed a predominance of genogroup I (GI), followed by GII and GIV. The detection
of multiple genotypes suggests the circulation of different strains without any clear tendency. The
results obtained suggest SaV as the second major gastroenteritis agent after NoV in the region.
Keywords: sapovirus; gastroenteritis; RT-qPCR; genotyping
1. Introduction
Foodborne diseases have been, during the last years, the eighth major cause of human deaths,
becoming third on the African continent, and have been the cause of 9% of mortalities in children
worldwide, according to the Global Health Observatory [1]. Parasites, bacteria, and viruses are
the infectious agents causing the thousands of deaths every year associated with these illnesses.
Enteric viruses are among the major contributors, including a wide range of etiological agents such as
adenovirus (AdV), astrovirus, rotavirus (RV), aichivirus, sapovirus (SaV), hepatitis A and E virus, and
norovirus (NoV). Most of them are considered foodborne viruses, but their transmission occurs not
only via the ingestion of infected food and water (the irrigation of fruits and vegetables, and shellfish
harvested in polluted waters), but also via person-to-person contact (infected workers and handlers),
contaminated environments, and fomites. They are characterized by low infectious doses and high
levels of viral excretion [2].
The genus Sapovirus, from the family Caliciviridae, has been recently included into the
Contaminant Candidate List (CCL4) by the U.S. Environmental Protection Agency as an emerging
microbial agent producing mild gastrointestinal illness [3]. SaV are classified into five genogroups,
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four of which (I, II, IV, V) infect humans, even though the existence of several additional genogroups
infecting different animals has been suggested [4,5]. The morphology corresponds to a non-enveloped
30–38 nm diameter icosahedral virus, with single-stranded positive-sense RNA and a genome
containing two or three open reading frames, depending on the genogroup [4].
Outbreaks happen throughout the year in all age groups in different settings, such as in childcare
centers, schools, colleges, hospitals, restaurants, hotels, and cruises. SaV transmission occurs by the
cited fecal–oral route and, similar to NoV, may have a very low infectious dose [4]. The incubation
period lasts from less than a day until four days [6]. Patients present acute diarrhea (with excretion of
105 to 1011 SaV genome copies per gram of stool (GC/g)) and vomiting as major symptoms, although
abdominal pain, chills, and headaches have also been reported [7]. Illness is usually self-limiting,
with therapy just for dehydration and electrolyte imbalances, although some individuals may require
hospitalization [7]. Shedding levels persist on high even several weeks after (more than 105 GC/g) [8],
and no or limited long-term immunity results from infection, meaning that one person may be
repeatedly infected. In addition, asymptomatic cases have been reported [9].
The main purpose of the study was to determine the presence of human SaV circulating in the
Spanish population in the Galician region over one year, taking into account an age group classification
as well as the drifts in time of the different genotypes.
2. Materials and Methods
2.1. Sampling
The study comprised stool samples from a total of 2667 outpatients suffering from acute
gastroenteritis treated at the University Hospital of A Coruña city, in Spain, which serves more
than half a million people. Samples were divided by age group as follows: 0–2 (n = 886), 3–5 (n = 195),
6–12 (n = 244), 13–18 (n = 71), 19–59 (n = 653),≥60 (n = 597), and unspecified age (n = 21). Sampling was
carried out from July 2010 to June 2011, and between 31 and 112 stool samples were received weekly at
the laboratory (58 on average). Coinfection analysis was performed with previously obtained data for
RV, AdV, and bacterial pathogens detected at the hospital, and for human NoV genogroups I (GI) and II
(GII) at our laboratory [10]. This study was carried out in accordance with the Declaration of Helsinki,
as revised in 2000. This non-interventional study included no additional procedures. Anonymized
biological material was obtained only for standard viral diagnosis. The Spanish Biomedical Research
Law (14/2007; article 3i) does not require written informed consent for such a protocol.
2.2. Viral RNA Extraction
The samples employed were previously processed, and viral RNA was extracted during the cited
study [10]. Briefly, they were diluted at 10% (w/v) in supplemented phosphate-buffered saline (PBS),
shaken, and centrifuged for viral recovery. RNA extraction was carried out using a NucleoSpin® RNA
Virus kit (Macherey-Nagel, Düren, Germany) and by adding known amounts of Mengovirus clone
vMC0 (MG) as an extraction efficiency control. In the case of a low volume of original extracted RNA or
of low extraction efficiencies, viral RNA was re-extracted from the original stool sample homogenates
and stored in our facilities at −80 ◦C.
2.3. Reverse Transcription (RT)-qPCR Methodology
Detection and quantification methodologies were based on the principles established in the latest
ISO procedures for enteric viruses [11,12]. The protocol described by Oka et al. [13] was employed
with minor modifications. Briefly, reverse primer SaV1245R (5’-CCCTCCATYTCAAACACTA-3´),
forward primer SaV124F (5´-GAYCASGCTCTCGCYACCTAC-3´), and TaqMan probe SaV124TP
(5´-FAM-CCRCCTATRAACCA-MGB-NFQ-3´) were utilized under the following thermal conditions:
Reverse transcription at 50 ◦C for 20 min, denaturation at 95 ◦C for 15 min, continued by 45
amplification cycles with denaturation at 95 ◦C for 15 s and annealing and elongation at 50 ◦C
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for 1 min. RT-qPCR was conducted using a Platinum Quantitative RT-PCR ThermoScript One-Step
System kit (Invitrogen, Carlsbat, CA, USA) in an MX3000P QPCR System thermocycler (Stratagene,
SanDiego, CA, USA) in 96-well plates.
For all the samples, a dilution of 1:10 was also tested to reduce the effect of potential polymerase
inhibitors present in the matrix, and for some samples a dilution of 1:100 was necessary as well. The
negative control for each assay consisted of a well in the plate with nuclease-free water and the same
RT-qPCR mix. The extraction efficiency control by MG consisted of a comparison between the threshold
cycle value (Ct) of the MG positive control and the Ct for each analyzed sample: The efficiency was
considered valid if above 5%. The presence of polymerase inhibitors and the RT-qPCR efficiency
were calculated using external controls (ECs) in each assay plate, consisting of independent wells
with 2.5 µL of sample and 2.5 µL SaV positive control. Ct values of the ECs were compared to those
of the positive control well, and the amplification was considered valid if the efficiency was above
25%. Control materials were obtained by cloning the 112 bp target fragment of the polymerase-capsid
junction (nucleotide positions 5073–5184 of GI Sapporo strain full-length genome, accession number
HM002617) into pGEM-T easy plasmid, transforming Escherichia coli DH5a competent cells, and then
purifying and quantifying using spectrophotometry (A260 nm). After this, standard curves were
calculated using serial dilutions. Neither the extraction efficiency nor the RT-qPCR efficiency were
used to modify the quantification values obtained in the samples. The limit of detection (LOD) was
settled in 5.2 × 102 GC/g, and the limit of quantification (LOQ) in 2.2 × 103 GC/g.
2.4. Genetic Analysis
Genotyping of the detected SaV strains was carried out using an RT-nested PCR protocol that
amplifies a partial fragment of the capsid gene of human genogroups [14]. RT consisted of 5 µL of
positive SaV RNA template in a final volume of 20 µL mix, using a RevertAid Reverse Transcriptase
kit (Thermo Scientific, USA) with reverse primers SV-R13 (5′-GGTGANAYNCCATTKTCCAT-3′)
and SV-R14 (5′-GGTGAGMMYCCATTCTCCAT-3′) (1 µM) for 60 min at 42 ◦C. First-round
PCR was conducted using 5 µL of cDNA in a final volume of 50 µL, with the same reverse
primers and forward primers, SaV124F, SaV1F (5′-TTGGCCCTCGCCACCTAC-3′), and SaV5F
(5′-TTTGAACAAGCTGTGGCATGCTAC-3′) (all 0.5 µM). Amplification conditions were 94 ◦C for 2
min denaturation, then 40 cycles of 94 ◦C for 30 s denaturation, 50 ◦C for 30 s for primer annealing,
72 ◦C for 2 min for extension, and finally 72 ◦C for 10 min for late extension. Second-round
PCR was performed for 45 cycles under similar conditions (extension 1 min) with primers SV-R2
(5′-GWGGGRTCAACMCCWGGTGG-3′) and 1245Rfwd (5′- TAGTGTTTGARATGGAGGG-3′) (0.5 µM)
and 5 µL from the first-round PCR product. Both amplifications were performed with a Fermentas
DreamTaq DNA Polymerase kit (ThermoScientific, Waltham, MA, USA). Nested-PCR products were
visualized in 2% agarose electrophoresis gels, and amplicons approximately 420 bp in size were
considered for purification and sent to be genotyped.
The obtained sequences were aligned and analyzed with software packages Lasergene 7
(DNASTAR Inc., Madison, WI, USA) and MEGA version 6 [15]. Neighbor-joining (NJ) phylogenetic
dendrograms were constructed with software MEGA version 6 using a Kimura two-parameter model
(bootstrap of 1000 replicates). SaV reference strains were retrieved from GenBank, and the strains
obtained in this study are also available at GenBank under accession numbers LT985022-LT985081,
LT985914-LT985948, and LT986236-LT986326.
2.5. Statistics
Statistical analysis was conducted with R Statistical Software version 3.4.3 (R-Project, Vienna,
Austria). Analytical experimental data on detection frequencies were analyzed through a chi-square
test to determine if the SaV prevalence was dependent on age. In the same way, quantification results
were converted into a logarithmic format and tested with a one-way analysis of variance (ANOVA) to
study any relationship between the SaV viral loads and the age groups [16].
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3. Results
3.1. Prevalence
Extraction and RT-qPCR efficiencies were classified as valid in all cases (>5% and >25%,
respectively). Molecular assays were performed in the 2667 stool samples, and human SaV was
detected in 417 (15.64%) of them. The results obtained showed that human SaV was present in all age
groups, with a higher incidence in infants under 2 years old (173/886, 19.5%) and in children 3–5 years
old (35/195, 17.9%). The rest of the age groups rendered as follows: 6–12 (29/244, 11.9%), 13–18
(7/71, 9.9%), 19–59 (79/653, 12.1%), and ≥60 (90/597, 15.1%). Statistical analysis with a chi-squared
test showed a significant association of SaV detection with age group (p = 5.9 × 10−4). Prevalence
decreased from childhood to the adult years, and it rose again in elders above 60 years old (Figure 1).
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detections, 6 samples were positive for Campylobacter spp., 3 samples for Salmonella spp., 2 samples 
for Bacillus cereus, and 1 sample presented Pseudomonas aeruginosa, too. Among those other 71 SaV–
NoV GII-positive samples, bacterial pathogens Staphylococcus aureus and Yersinia enterocolitica were 
present in 1 patient for each one, and Salmonella spp. in another 2 cases. On the other hand, some 
pediatric cases were also previously analyzed at the hospital for RV and AdV (total of 125), and 3 
coinfections were detected with SaV–RV, 2 with SaV–RV–AdV, and 1 with SaV–RV–NoV GII (Figure 
2). 
Figure 1. Sapovirus (SaV)-negative (light gray) and -positive samples (black), as well as human SaV
prevalence within the different age groups.
3.2. Coinfection
From the 417 total SaV positive samples, 196 presented at least another gastroenteric microbial
pathogen (Figure 2). SaV showed coinfection with NoV in 164 cases, of which 85 were with genogroup
I (GI), 71 with genogroup II (GII), and 8 with both genogroups. Of those 85 SaV–NoV GI detections, 6
samples were positive for Campylobacter spp., 3 samples for Salmonella spp., 2 samples for Bacillus cereus,
and 1 sample presented Pseudomo as aeruginosa, too. Among those other 71 SaV–NoV GII-positiv
samples, bacterial pathogens Staphylococcus aureus and Yersinia enterocolitica were present in 1 patient
for each one, and Salmonella spp. in another 2 cases. On the other hand, some pediatric cases were also
previously analyzed at the hospital for RV and AdV (total of 125), and 3 coinfections were detected
with SaV–RV, 2 with SaV–RV–AdV, and 1 with SaV–RV–NoV GII (Figure 2).
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Figure 2. Diagram showing the number of SaV coinfections with other viral and bacteriological agents.
Data for other pathogens obtained from a previous study [10].
When analyzing these results, taking into account the age group classification, it was observed
that in the 0–2 age group, all the SaV–RV coinfections (including SaV–RV–AdV) occurred, as well
as most of the detected coinfections with Campylobacter spp. and Salmonella spp. (Supplementary
Materials, Figure S1A). Apart from that, the combined presence of SaV with NoV GI and Bacillus cereus
was only detected in the 19–59 age group, and other different coinfections with Pseudomonas aeruginosa,
Aeromonas spp., or E. coli 0157:H7 occurr d just in the ≥60-year-old age group (Supplementary
Materials, Figure S1E,F).
With the previous and actual analysis gathered for single detections and coinfections, the possible
etiology of the illness could be elucidated for 47.4% of the examined gastroenteritis cases included in
this study.
3.3. Seasonality
The highest number of SaV detections was not observed during the coldest and rainiest months
of the study, but in early autumn and late winter to early spring (Figure 3). September, October, and
February showed important prevalence percentages (21.6%, 20.4%, and 21.1%, respectively), and
prevalence kept high until spring. All age groups followed this pattern, although prevalence in the
≥60 group presented an increasing tendency from November (Figure 3A).
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3.4. Quantification
A total of 129 positive samples ranged below the LOQ (2.2 × 103 GC/g). The other 288 cases
rendered an overall mean value of 6.5 × 105 GC/g, with a minimum value of 2.4 × 103 GC/g and
a maximum of 6.6 × 1011 GC/g (Figure 4). Variations among viral loads in the age groups were
significant when analyzed by ANOVA (p = 2.0 × 10−4). The age group between 0 and 2 presented
the highest quantification, and elders (≥60 years old) the lowest. When comparing the age groups of
infants and children to the elderly, the differences in quantification were 1.5 log units between 0 and 2
and ≥60 (p = 1.4 × 10−7), and 1.0 log unit between 3 and 5 and ≥60 (p = 0.037) (Figure 4).
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3.5. Genetic Characterization
Sequences suitable for genetic characterization were obtained for 186 positive samples. Of them,
126 samples corresponded to genogroup I, 55 samples to genogroup II, and 5 samples to genogroup
IV (Figure 5; Supplementary Materials, Figure S2). Genogroup I sequences were classified into GI.1
(n = 91) (the most predominant genotype), GI.2 (n = 32), and GI.3 (n = 3). On the other side, genogroup
II sequences were split into genotypes GII.1 and GII.4 (n = 27 and n = 21, respectively), genotype GII.5
(n = 6), and GII.2 (n = 1).
The temporal distribution of the different genotypes showed a predominance of GI.1 during the
first quarter of the study, approximat ly from July until the end of October, followed by a decrease in
the over ll detection during late autumn to early winter. Later, the general diversity increased with
detections of genotypes GI.2 and GII.1 and the appeara c of GII.4. At the end of the study, only GI.1
and GII.4 remained as dominant genotypes (Figure 6).
Although GI.3 sequences (n = 3) were only detected in infants 0–2 and children 3–5, and genogroup
IV cases did not occur during childhood periods (Table 1), no clear tendency was observed for the
most prevalent genotypes, as GI.1, GI.2, GII.1, and GII.4 sequences were present in all groups.
Short-term upturns of certain genotypes, namely GI.1 and GII.4, were observed throughout the
study. The samples in each of these groups showed 100% nucleotide identity, which could indicate the
appearance of SaV outbreaks in the population (Supplementary Materials, Figure S2). However, the
linkage among cases or the existence of a common viral vehicle could not be confirmed due to the lack
of epidemiological data.
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joining algorithm. Bootstrap values (greater than 70%) are shown at each node as percentages of 1000 
replicates. Reference sequences are in boldface italics. Porcine enteric calicivirus (Cowden) classified 
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Figure 5. Phylogenetic tree based on the partial capsid gene sequences of SaV using the neighbor-joining
algorithm. Bootstrap values (greater than 70%) are shown at each node as percentages of 1000 replicates.
Reference sequences are in boldface italics. Porcine enteric calicivirus (Cowden) classified as GIII was
used as outgroup. GenBank accession numbers of the reference strains used are detailed in the tree.
Bar: Nucleotide substitutions per site.
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4. Discussion
The present study provides novel data about the role of SaV in patients with an acute
gastroenteritis diagnosis receiving health care in Spain. Putting together our results with those
from a previous study [10], from the 2667 cases, etiology was established in 47.4% of them, including
both bacterial and viral agents.
Most of the SaV long-term studies worldwide have shown prevalence rates ra ging from 2.2% o
12.7% [4], and many have been locat d, as in this research, in developed countries such as Japan, the
U.S., or the U.K. [17–19]. The present study showed slightly h gher SaV prevalence (15.6%), more in
line w th the 17% positive rate found in Nicaragua [20].
re ver, patients 0–2 and 3–5 years old presented the highest positive rates, which was in
accordance with the established notion of higher prevalence of this path g n in children [19,21]. Elder
people ≥60 presented 15. % prevalence, demon trating that together with infants, they are considered
to be the most vulnerable populati n against vi l acute gastroenteritis [22].
ix d infections in patients could lead to mo sev re gastroint tinal symptoms, and therefore,
nalyses of clinical ca es for more ha one viral agent are needed. In 164 samples (39.3%), NoV and
SaV were simultaneously det cted, which wa a much higher level than what can be found in the
literature, where mixed infections with both calicivir s s do not usually exceed 10% of cases [17–20].
NoV–SaV mixed infections in the present study c uld be explained by he elevated prevalence of SaV,
compared to other surveys. Pediatric coinf ct ons with RV are scarce [18,19], and only occurred in six
c ses in this st dy, three of which showed triple mixed infections: Two with SaV–RV–AdV and on
with SaV–RV–NoV.
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Regarding seasonality, SaV was detected throughout the entire period, with higher incidence
in September, October, and from February to May, in line with other studies [23–25], where its
prevalence was high during spring months. Our results were in concordance with the normally
accepted hypothesis that SaV is mostly detected in the cold and rainy seasons [26,27]. Observing the
results previously obtained [10], the highest prevalence rates of NoV cases occurred between November
and January, when SaV prevalence was at its lowest: Moreover, NoV prevalence rates decreased during
the mentioned SaV high peaks of abundance (data not shown). Since, to our knowledge, no other work
about SaV prevalence on a weekly basis has been reported, it is difficult to confirm if this alternance
between both viruses has been detected in other geographic regions. However, a possible similar trend
could be inferred from the studies of Pongsuwanna et al. [28] and Shioda et al. [29] in Thailand and
Kenya, respectively.
The mean value of the quantified samples was 6.5 × 105 GC/g of stool, which was in accordance
with most of the studies providing information about shedding levels [8]. These levels gradually
decreased after onset of illness, and therefore, based on the detection of mixed infection, some low viral
load quantification cases (also under LOQ) could be, hypothetically, a combination of late SaV and
early coinfection with other pathogens, which could cause severe symptoms of acute gastroenteritis
with hospital care requirements.
Genetic analysis is crucial to elucidate the current circulating SaV in the population regionally and
worldwide. Investigations have revealed that GI and GII are the most common SaV genogroups [30].
Genotype I.1 is the most common genotype around the globe, and GI.2 has been increasingly detected
in many European countries [31], and also in northern Africa [32]. The results from this research
support those from previous studies, as GI.1 and GI.2 were the two most abundant SaV genotypes
(91 and 32 cases, respectively), followed by GII.1. It is noteworthy to point out the detection of some
sequences belonging to rare SaV genotypes [33], including GII.4 (21 sequences), GII.5 (6 sequences),
and GI.3 (3 sequences). Genotype GII.4 SaV was also recently detected in Thailand [34]. On the other
hand, GIV was indeed a genotype normally detected at high rates in developed countries around
2007 [4], but not so much in this study. Environmental studies conducted in Spain have obtained
findings that mirror what was observed in this study, showing a rich variety of sequences circulating,
especially genotypes GI.1 and GI.2 [14,35,36].
Surveillance systems in hospitals and healthcare centers are mostly limited to detecting bacterial
pathogens. Since many emerging enteric viruses produce mild and often uninvestigated infections,
their recognition as possible critical human pathogens has been underestimated. Most of them are
difficult to study and have symptoms similar to those caused by bacterial pathogens. This study should
help to position human SaV, at least, as one of the foremost causes of nonbacterial acute gastroenteritis
agents in Spain, especially in some age groups.
Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4915/11/2/144/s1,
Figure S1: Coinfection cases of SaV with other viral and bacteriological agents for the different age groups analyzed;
Figure S2: Similarity matrices obtained by MegAlign of the sequence analysis for each of the genotype upturns.
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